1. Bray, F, Ferlay, J, Soerjomataram, I, Siegel, RL, Torre, LA, Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424.
Google Scholar | Crossref | Medline2. Adeloye, D, Sowunmi, OY, Jacobs, W, et al. Estimating the incidence of breast cancer in Africa: a systematic review and meta-analysis. J Glob Health. 2018;8:010419. doi:10.7189/jogh.08.010419.
Google Scholar | Crossref | Medline3. Lanta, Q, Arveux, P, Asselain, B. Epidemiology and socio-cultural specificities of young women with breast cancer. Bull Cancer. 2019;106:S4-S9.
Google Scholar | Crossref | Medline4. Hélène, SG, Marc, C. Breast cancer epidemiology. Presse Med. 2019;48:1076-1084.
Google Scholar | Medline5. Brinton, LA, Figueroa, JD, Awuah, B, et al. Breast cancer in sub-Saharan Africa: opportunities for prevention. Breast Cancer Res Treat. 2014;144:467-478.
Google Scholar | Crossref | Medline | ISI6. Joko-Fru, WY, Miranda-Filho, A, Soerjomataram, I, et al. Breast cancer survival in sub-Saharan Africa by age, stage at diagnosis and human development index: a population-based registry study. Int J Cancer. 2020;146:1208-1218.
Google Scholar | Crossref | Medline7. Darré, T, Tchaou, M, Folligan, K, et al. Breast cancer cases of female patients under 35 years of age in Togo: a series of 158 cases. Mol Clin Oncol. 2017;7:1125-1129.
Google Scholar | Medline8. Ly, M, Antoine, M, André, F, Callard, P, Bernaudin, JF, Diallo, DA. Breast cancer in sub-Saharan African women: review. Bull Cancer. 2011;98:797-806.
Google Scholar | Crossref | Medline9. Bray, F, Ren, JS, Masuyer, E, Ferlay, J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132:1133. doi:10.1002/ijc.27711.
Google Scholar | Crossref | Medline | ISI10. Guennoun, A, Krimou, Y, Bouchikhi, C, Mamouni, N, Errarhay, S, Banani, A. Corrélation radio-histologique des lésions mammaires ACR4: à propos de 181 cas et revue de la littérature [Radio-histological correlation of ACR4 microcalcifications in breast lesions: about 181 cases and literature review. Pan Afr Med J. 2018;29:140. doi:10.11604/pamj.2018.29.140.13699.
Google Scholar | Crossref | Medline11. Qian, F, Ogundiran, T, Hou, N, et al. Alcohol consumption and breast cancer risk among women in three sub-Saharan African countries. PLoS ONE. 2014;9:e106908.
Google Scholar | Crossref | Medline12. Pace Shulman, LN . Breast cancer in sub-Saharan Africa: challenges and opportunities to reduce mortality. Oncologist. 2016;21:739-744.
Google Scholar | Crossref | Medline13. Darre, T, Kpatcha, TM, Bagny, A, et al. Descriptive epidemiology of cancers in Togo from 2009 to 2016. Asian Pac J Cancer Prev. 2017;18:3407-3411.
Google Scholar | Medline14. Harris, L, Fritsche, H, Mennel, R, et al. American Society of Clinical Oncology 2007 update of recommendation for use tumor markers in breast cancer. J Clin Oncol. 2007;25:5287-5212.
Google Scholar | Crossref15. Zonderland, HM, Pope, TL, Nieborg, AJ. The positive predictive value of the breast imaging reporting and data system (BI-RADS) as a method of quality assessment in breast imaging in a hospital population. Eur Radiol. 2004;14:1743-1750. doi:10.1007/s00330-004-2373-6.
Google Scholar | Crossref | Medline16. Blows, FM, Driver, KE, Schmidt, MK, et al. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med. 2010;7:e1000279. doi:10.1371/journal.pmed.1000279.
Google Scholar | Crossref | Medline | ISI17. Parise, CA, Bauer, KR, Brown, MM, Caggiano, V. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004. Breast J. 2009;15:593-602.
Google Scholar | Crossref | Medline | ISI18. Balekouzou, A, Yin, P, Bekolo, CE, et al. Histo-epidemiological profile of breast cancers among women in the Central African Republic: about 174 cases. BMC Cancer. 2018;18:387. doi:10.1186/s12885-018-4256.
Google Scholar | Crossref | Medline19. Fitzpatrick, MB, Rendi, MH, Kiviat, NB, et al. Pathology of Senegalese breast cancers. Pan Afr Med J. 2019;34:67. doi:10.11604/pamj.2019.34.67.17993.
Google Scholar | Crossref | Medline20. da Costa Vieira, RA, Biller, G, Uemura, G, Alberto Ruiz, C, Paula Curado, M. Breast cancer screening in developing countries. Clinics (Sao Paulo). 2017;72:244-253.
Google Scholar | Crossref | Medline21. Kemo, ADD, Nkegoum, B, Nangue, C, Djuikwo, F, Bita’a, LB, Tebeu, PM. Histo-epidemiological aspects of gynecological and breast cancers at the University Teaching Hospital of Yaoundé. Pan Afr Med J. 2019;33:130. doi:10.11604/pamj.2019.33.130.18874.
Google Scholar | Crossref | Medline22. Lowery, AJ, Miller, N, Devaney, A, et al. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res. 2009;11:R27. doi:10.1186/bcr2257.
Google Scholar | Crossref | Medline23. Kurian, AW, Fish, K, Shema, SJ, Clarke, CA. Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res. 2010;12:R99. doi:10.1186/bcr2780.
Google Scholar | Crossref | Medline24. Colonna, M, Delafosse, P, Uhry, Z, et al. Is breast cancer incidence increasing among young women? An analysis of the trend in France for the period 1983-2002. Breast. 2008;17:289-292.
Google Scholar | Crossref | Medline25. Sutton, T, Reilly, P, Johnson, N, Garreau, JR. Breast cancer in women under 50: most are not high risk. Am J Surg. 2018;215:848-851.
Google Scholar | Crossref | Medline26. Soerjomataram, I, Lortet-Tieulent, J, Parkin, DM, et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012;380:1840-1850.
Google Scholar | Crossref | Medline27. Engbang, JP, Koh, VM, Tchente, CN, Fewou, A. Histo-epidemiological aspects of genital cancers in women in the Littoral Region, Cameroon. Pan Afr Med J. 2015;21:116. doi:10.11604/pamj.2015.21.116.6755.
Google Scholar | Crossref | Medline28. Edmund, DM, Naaeder, SB, Tettey, Y, Gyasi, RK. Breast cancer in Ghanaian women: what has changed? Am J Clin Pathol. 2013;140:97-102.
Google Scholar | Crossref | Medline29. Ohene-Yeboah, M, Adjei, E. Breast cancer in Kumasi, Ghana. Ghana Med J. 2012;46:8-13.
Google Scholar | Medline30. Lin, W, Cen, YL, Lin, Y, et al. Joint effects between urinary selenium and polymorphisms in methylation related genes on breast cancer risk. Neoplasma. 2015;62:491-499.
Google Scholar | Crossref | Medline31. Darre, T, Tchaou, M, Djiwa, T, et al. Male breast cancer in Togo: imaging and clinicopathological findings. Int J Breast Cancer. 2020;2020:3056067. doi:10.1155/2020/3056067.
Google Scholar | Crossref | Medline32. Effi, AB, Aman, NA, Koui, BS, Koffi, KD, Traoré, ZC, Kouyate, M. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast. BMC Cancer. 2017;17:115. doi:10.1186/s12885-017-3105-z.
Google Scholar | Crossref | Medline33. Ginsburg, O, Bray, F, Coleman, MP, et al. The global burden of women’s cancers: a grand challenge in global health. Lancet. 2017;389:847-860.
Google Scholar | Crossref | Medline34. Lukong, KE, Ogunbolude, Y, Kamdem, JP. Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants. Breast Cancer Res Treat. 2017;166:351-365.
Google Scholar | Crossref | Medline35. Frandsen, J, Cannon, G, Kokeny, KE, et al. Post-mastectomy radiotherapy for pT3N0 breast cancers: a retrospective, multi-institution review. Breast J. 2017;23:452-455.
Google Scholar | Crossref | Medline36. Vuong, D, Simpson, PT, Green, B, Cummings, MC, Lakhani, SR. Molecular classification of breast cancer. Virchows Arch. 2014;465:1-14.
Google Scholar | Crossref | Medline